ES2184812T3 - Patrones para el dosificado inmunologico de esteroides estabilizados en solucion acuosa. - Google Patents

Patrones para el dosificado inmunologico de esteroides estabilizados en solucion acuosa.

Info

Publication number
ES2184812T3
ES2184812T3 ES95939157T ES95939157T ES2184812T3 ES 2184812 T3 ES2184812 T3 ES 2184812T3 ES 95939157 T ES95939157 T ES 95939157T ES 95939157 T ES95939157 T ES 95939157T ES 2184812 T3 ES2184812 T3 ES 2184812T3
Authority
ES
Spain
Prior art keywords
steroids
stabilized
patterns
chelators
water solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95939157T
Other languages
English (en)
Inventor
Gregg T Williams
Steven C Kuemmerle
Hoda I Aboleneen
William R Groskopf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2184812T3 publication Critical patent/ES2184812T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LAS SOLUCIONES ACUOSAS DE COMPUESTOS ESTEROIDEOS CON ACTIVIDAD BIOLOGICA Y CON TENDENCIA A LA DEGRADACION OXIDATIVA A TEMPERATURAS ENTRE 2 Y 8 (GRADOS) C DURANTE LA CONSERVACION EN EXCESO DE VARIOS MESES SE ESTABILIZAN MEDIANTE ADICION DE QUELANTES. SOLUCIONES ACUOSAS CON UN INTERES PARTICULAR SON SOLUCIONES CON PROTEINAS QUE SIMULAN EL COMPORTAMIENTO DE FLUIDOS CORPORALES HUMANOS COMO SUERO Y QUE POR LO TANTO SON ADECUADOS COMO ESTANDARES PARA INMUNOENSAYOS DE ESTEROIDES EN DICHOS FLUIDOS CORPORALES. TIENEN UN INTERES PARTICULAR LOS QUELANTES METALES DE TRANSICION, ESPECIALMENTE AQUELLOS QUE SECUESTRAN HIERRO EFICIENTEMENTE.
ES95939157T 1994-11-28 1995-11-13 Patrones para el dosificado inmunologico de esteroides estabilizados en solucion acuosa. Expired - Lifetime ES2184812T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34518194A 1994-11-28 1994-11-28

Publications (1)

Publication Number Publication Date
ES2184812T3 true ES2184812T3 (es) 2003-04-16

Family

ID=23353908

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95939157T Expired - Lifetime ES2184812T3 (es) 1994-11-28 1995-11-13 Patrones para el dosificado inmunologico de esteroides estabilizados en solucion acuosa.

Country Status (8)

Country Link
US (1) US6767708B1 (es)
EP (1) EP0795134B1 (es)
JP (1) JP3560979B2 (es)
AT (1) ATE223060T1 (es)
CA (1) CA2204027C (es)
DE (1) DE69527977T2 (es)
ES (1) ES2184812T3 (es)
WO (1) WO1996017252A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797479B2 (en) * 1995-04-04 2004-09-28 Abbott Laboratories Reagents and methods for the detection and quantification of vancomycin in biological fluids
US5699838A (en) 1995-05-22 1997-12-23 Inliner, U.S.A. Apparatus for vacuum impregnation of a flexible, hollow tube
US20030215952A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US6475743B1 (en) * 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US20020137097A1 (en) * 2000-12-13 2002-09-26 Bio-Rad Laboratories, Inc. Standard diluent for multiplex assays
US20040261816A1 (en) * 2003-06-27 2004-12-30 Brask Justin K. Using bidentate chelators to clean semiconductor wafers
US20070141710A1 (en) * 2005-12-20 2007-06-21 Beckman Coulter, Inc. Stable calibrators for immunoassays
DK2116241T3 (en) 2007-01-26 2016-06-06 Pola Pharma Inc pharmaceutical composition
CN110579615A (zh) * 2019-09-06 2019-12-17 广州科方生物技术股份有限公司 一种通用于血清中类固醇激素的释放剂及其制备方法
CN117825476B (zh) * 2024-01-10 2024-08-30 上海原科实业发展有限公司 一种血清蛋白电泳质控品及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274062A (en) * 1963-08-20 1966-09-20 Hyland Lab Diagnostic reagent
US4786606A (en) * 1981-01-23 1988-11-22 Baxter Travenol Laboratories, Inc. Solid phase system for ligand assay
DE3122917A1 (de) * 1981-06-10 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim Waessrige cholesterin-standardloesung und verfahren zu ihrer herstellung
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4344940A (en) * 1981-11-30 1982-08-17 E. R. Squibb & Sons, Inc. Steroid formulation containing dipotassium EDTA
US4436738A (en) * 1982-03-15 1984-03-13 Mead Johnson & Company Stabilized estradiol cream composition
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
DE3445010A1 (de) * 1984-12-10 1986-06-19 Boehringer Mannheim Gmbh Kontroll- bzw. eichserum fuer die lipid-diagnostik
US4707453A (en) * 1985-04-05 1987-11-17 Becton Dickinson And Company Vesicle including a metal marker for use in an assay
GB8800078D0 (en) * 1988-01-05 1988-02-10 Ciba Geigy Ag Novel antibodies
US5342760A (en) * 1992-06-10 1994-08-30 Abbott Laboratories Determination of estradiol by competitive immunoassay
US5296377A (en) * 1992-12-15 1994-03-22 Boehringer Mannheim Corporation Control reagent containing a hydroxylamine or an antioxidant

Also Published As

Publication number Publication date
JPH10512362A (ja) 1998-11-24
EP0795134A1 (en) 1997-09-17
CA2204027C (en) 2006-03-14
US6767708B1 (en) 2004-07-27
CA2204027A1 (en) 1996-06-06
DE69527977D1 (de) 2002-10-02
ATE223060T1 (de) 2002-09-15
DE69527977T2 (de) 2003-05-08
EP0795134B1 (en) 2002-08-28
WO1996017252A1 (en) 1996-06-06
JP3560979B2 (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
ES2184812T3 (es) Patrones para el dosificado inmunologico de esteroides estabilizados en solucion acuosa.
NO1994018I1 (no) Mometasonfuroat
MX155757A (es) Composicion mejorada para acondicionar el cabello
IL142824A (en) Lipoic acid derivatives and their use as anti metabolic agents
DK588487D0 (da) Forbedrede metalholdige farmaceutiske midler
ATE86294T1 (de) Verwendung kurzkettiger alkansulfonsaeuren in reinigungs- und desinfektionsmitteln.
PT1124535E (pt) Sistema conservante para composicoes farmaceuticas topicamente administraveis contendo um sabao de acido gordo/amino acido
EA199900876A1 (ru) Фармацевтические композиции против кашля
ES8403623A1 (es) Procedimiento para la determinacion de bilirrubina directa y total en liquidos corporales.
DK319484A (da) Imidazol-2-ylthioalkansyrer, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DE59103442D1 (de) Therapeutisch wirksames stoffgemisch aus glutathion- und anthocyan-verbindungen.
PT74229A (de) Verwendung von waessrigen natrium-oder kaliummethioninat-loe- sungen zur supplementierung von mischfuttern mit methionin
IT8125358A0 (it) Bioprotesi valvolare cardiaca e suo procedimento di ottenimento.
DE69017969D1 (de) 2-Cyclohexylpropionsäure oder Derivate davon enthaltende Riechstoffzusammensetzung.
ES516422A0 (es) "procedimiento e instalacion para la obtencion de metano y para el tratamiento de liquidos acuosos que contengan sustancias organicas".
IT7819469A0 (it) Valvola per l'erogazione separata di due componenti e per la loro miscelazione all'esterno della stessa.
JPS51121521A (en) Deodorant compositions
JPS5562013A (en) Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent
NO793974L (no) 1,3,4-thiadiazol-2-carboxylsyrederivater, fremgangsmaater for fremstilling av disse forbindelser, saavel som fungicide og nematicide midler inneholdende disse forbindelser
IT8224960A0 (it) Derivati di tetraidrobenzotiazolo e composizioni erbicide che licontengono come ingredienti attivi.
ES8407031A1 (es) "procedimiento para la preparacion de n-(2-metil--5-cloro-fenil)-n-metoxiacetil-3-amino-1,3-oxazilidin-urea"
DK433882A (da) 1,2,3-thiadiazol-5-yl-urinstofderivater, fremgangsmaade til fremstilling af disse forbindelser samt midler indeholdende disse forbindelser med vaekstregulerende og afbladende virkning
IT1116518B (it) Composizione per prevenire o curare la dissenteria dei suini e relativo procedimento di impiego
IT8323139A0 (it) Caviglia per l'assemblaggio di parti di mobili.
JPS52110830A (en) Additive for improving blast inhibitor effectiveness and its usage